Mizuho Securities Starts Terns Pharmaceuticals (TERN) at Buy
Tweet
Share
E-mailGet Alerts TERN Hot Sheet
Price: $52.95 --0%
Rating Summary:
4 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
4 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Mizuho Securities analyst Graig Suvannavejh initiates coverage on Terns Pharmaceuticals (NASDAQ: TERN) with a Buy rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Terns Pharmaceuticals click here. For more ratings news on Terns Pharmaceuticals click here.
Shares of Terns Pharmaceuticals closed at $11.86 yesterday.
You May Also Be Interested In
- Raymond James Starts Southern California Bancorp (BCAL) at Outperform
- Baird Starts Hubbell (HUBB) at Outperform
- DA Davidson Starts Sterling Construction (STRL) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
